Panbela Therapeutics, Inc. (NASDAQ:PBLA) Q2 2023 Earnings Call Transcript August 10, 2023 Panbela Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.00795 EPS, expectations were $4.71. Operator: Greetings and welcome to the Panbela Therapeutics Second Quarter 2023 Earnings Call. [Operator Instructions] Please note this conference is being recorded. I will now turn the conference […]
Panbela Therapeutics, Inc. (NASDAQ:NASDAQ:PBLA) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants James Carbonara - Hayden IR Jennifer Simpson - CEO Susan.